ASCO 2022 Conference Coverage
ASCO 2022 on the Clinical Outcomes & Safety of Enzalutamide + ADT in mHSPC in Patients Aged <75 and ≥ 75 years: ARCHES Post Hoc Analysis
By
ASCO 2022 Conference Coverage
FEATURING
Russell Szmulewitz
By
ASCO 2022 Conference Coverage
FEATURING
Russell Szmulewitz
Comments 0
Login to view comments.
Click here to Login
